Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Raut M et al. - A relatively small decrease in LOS in CAP can have a substantial cost impact, with estimated savings of $457 to $846 per episode or $500-$900 million annually. Additional evaluation is warranted for interpreting these cost-savings in the context of current antibiotic prescribing patterns.

Related Articles

Influenza is a Major Contributor to Childhood Pneumonia in a Tropical Developing Country
The Pediatric Infectious Disease Journal, 10/05/09    Relevance Score: 93%

Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection
European Journal of Pediatrics, 11/17/09    Relevance Score: 92%

Discordant Chest Radiographs - A Pitfall in Febrile Elderly Patients With Pneumonia
International Journal of Gerontology, 10/09/09    Relevance Score: 92%

Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae
Journal of Medical Microbiology, 10/21/09    Relevance Score: 91%

Role of atypical pathogens among adult hospitalized patients with community-acquired pneumonia
Respirology, 10/09/09    Relevance Score: 90%

Today in Other Drugs...keeping you current

Vitiligo therapy
Expert Opinion in Pharmacotherapy, 12/01/09

A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients
Bone , 12/01/09

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address